Related changes

Jump to navigation Jump to search

Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.

Recent changes options Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 19:27, 28 June 2024
   
Page name:
List of abbreviations:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes

28 June 2024

 m   19:07  Tutorial diffhist -200 Jwarner talk contribs
 m   17:54  Non-small cell lung cancer‎‎ 2 changes history -527 [Warner-admin‎; Jwarner‎]
 m   
17:54 (cur | prev) -529 Jwarner talk contribs
 m   
17:33 (cur | prev) +2 Warner-admin talk contribs Text replacement - "http://ar.iiarjournals.org" to "https://ar.iiarjournals.org"
 m   17:33  Non-small cell lung cancer - historical diffhist +2 Warner-admin talk contribs Text replacement - "http://ar.iiarjournals.org" to "https://ar.iiarjournals.org"

27 June 2024

 m   21:36  Levels of Evidence diffhist -10 Jwarner talk contribs

23 June 2024

 m   12:20  Non-small cell lung cancer diffhist -35 Jwarner talk contribs
 m   12:19  Non-small cell lung cancer - historical diffhist -1,605 Jwarner talk contribs →‎Carboplatin & Paclitaxel (CP) & Vadimezan

22 June 2024

 m   02:22  Non-small cell lung cancer diffhist +131 Jwarner talk contribs →‎Cisplatin & Etoposide (EP) {{#subobject:gocg67|Regimen=1}}

18 June 2024

 m   10:54  Pembrolizumab (Keytruda)‎‎ 2 changes history +220 [Jwarner‎ (2×)]
 m   
10:54 (cur | prev) -2 Jwarner talk contribs
 m   
10:53 (cur | prev) +222 Jwarner talk contribs →‎Endometrial cancer

15 June 2024

 m   00:29  Durvalumab (Imfinzi)‎‎ 3 changes history +314 [Jwarner‎ (3×)]
 m   
00:29 (cur | prev) 0 Jwarner talk contribs
 m   
00:27 (cur | prev) +53 Jwarner talk contribs
 m   
00:25 (cur | prev) +261 Jwarner talk contribs →‎History of changes in FDA indication

2 June 2024

     22:05  Editorial board transclusions diffhist -307 Warner-admin talk contribs →‎Breast oncology

1 June 2024

 m   04:03  Nivolumab (Opdivo) diffhist +210 Jwarner talk contribs →‎Malignant pleural mesothelioma
 m   03:50  Pembrolizumab (Keytruda) diffhist +203 Jwarner talk contribs →‎Renal cell carcinoma